{
  "ticker": "CRL",
  "year": 2022,
  "quarter": 2,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 128,
  "transactions": [
    {
      "id": 24143,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 46452,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 80770,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 123355,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 171944,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 46433,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-06-06",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "211711"
    },
    {
      "id": 80744,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-06-06",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "211711"
    },
    {
      "id": 123329,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-06-06",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "211711"
    },
    {
      "id": 171916,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-06-06",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "211711"
    },
    {
      "id": 731,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 9549,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 24134,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 46432,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 80742,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 123327,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 171914,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 726,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 733,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 738,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 739,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 743,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 9544,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 9551,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 9557,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 9558,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 9562,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 24127,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 24137,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 24145,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 24146,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 24151,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 46424,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 46440,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 46457,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 46458,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 46464,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 80726,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 80753,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 80777,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 80778,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 80786,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 123310,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 123338,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 123362,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 123364,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 123373,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 171897,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 171925,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 171954,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 171956,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 171966,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 728,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 729,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 730,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 734,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 735,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 736,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 737,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 740,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 742,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 9546,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 9547,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 9548,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 9553,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 9554,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 9555,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 9556,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 9559,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 9561,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 24130,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 24131,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 24133,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 24139,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 24140,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 24142,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 24144,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 24148,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 24150,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 46427,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 46429,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 46431,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 46444,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 46446,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 46451,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 46453,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 46461,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 46463,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 80733,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 80735,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 80741,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 80758,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 80760,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 80769,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 80771,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 80781,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 80785,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 123317,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 123319,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 123325,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 123343,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 123345,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 123354,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 123356,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 123367,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 123372,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 171904,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 171906,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 171912,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 171931,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 171933,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 171943,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 171945,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 171960,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 171965,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 741,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 9560,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 24149,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 46462,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 80784,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 123371,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 171964,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 732,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 9550,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 24135,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 46434,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 80745,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 123330,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 171917,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    }
  ]
}